217 related articles for article (PubMed ID: 23646970)
1. The methylation hypothesis of pharmacoresistance in epilepsy.
Kobow K; El-Osta A; Blümcke I
Epilepsia; 2013 May; 54 Suppl 2():41-7. PubMed ID: 23646970
[TBL] [Abstract][Full Text] [Related]
2. The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis?
Kobow K; Blümcke I
Epilepsia; 2011 Jul; 52 Suppl 4():15-9. PubMed ID: 21732935
[TBL] [Abstract][Full Text] [Related]
3. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs.
Rogawski MA
Epilepsia; 2013 May; 54 Suppl 2():33-40. PubMed ID: 23646969
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cellular mechanisms of pharmacoresistance in epilepsy.
Remy S; Beck H
Brain; 2006 Jan; 129(Pt 1):18-35. PubMed ID: 16317026
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of drug resistance.
Löscher W
Epileptic Disord; 2005 Sep; 7 Suppl 1():S3-9. PubMed ID: 16120487
[TBL] [Abstract][Full Text] [Related]
6. Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.
Potschka H
Pharmacogenomics; 2010 Oct; 11(10):1427-38. PubMed ID: 21047204
[TBL] [Abstract][Full Text] [Related]
7. [Drug resistance in epilepsy].
Czuczwar P; Kaczmarczyk K; Wierzchowska-Cioch E; Łuszczki JJ; Czuczwar SJ
Przegl Lek; 2009; 66(11):963-6. PubMed ID: 20297639
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of drug resistance in epilepsy].
Lasoń W
Przegl Lek; 2006; 63(11):1218-20. PubMed ID: 17348420
[TBL] [Abstract][Full Text] [Related]
9. The molecular hallmarks of epigenetic effects mediated by antiepileptic drugs.
Navarrete-Modesto V; Orozco-Suárez S; Feria-Romero IA; Rocha L
Epilepsy Res; 2019 Jan; 149():53-65. PubMed ID: 30476813
[TBL] [Abstract][Full Text] [Related]
10. Diminished response of CA1 neurons to antiepileptic drugs in chronic epilepsy.
Schaub C; Uebachs M; Beck H
Epilepsia; 2007 Jul; 48(7):1339-50. PubMed ID: 17441992
[TBL] [Abstract][Full Text] [Related]
11. Impaired mitochondrial energy production: the basis of pharmacoresistance in epilepsy.
Yuen AW; Sander JW
Med Hypotheses; 2011 Oct; 77(4):536-40. PubMed ID: 21737204
[TBL] [Abstract][Full Text] [Related]
12. A conceptual framework for the use of neuroimaging to study and predict pharmacoresistance in epilepsy.
Pohlmann-Eden B; Crocker CE; Schmidt MH
Epilepsia; 2013 May; 54 Suppl 2():75-9. PubMed ID: 23646977
[TBL] [Abstract][Full Text] [Related]
13. Association of a synonymous GAT3 polymorphism with antiepileptic drug pharmacoresistance.
Kim DU; Kim MK; Cho YW; Kim YS; Kim WJ; Lee MG; Kim SE; Nam TS; Cho KH; Kim YO; Lee MC
J Hum Genet; 2011 Sep; 56(9):640-6. PubMed ID: 21776001
[TBL] [Abstract][Full Text] [Related]
14. Plasticity of antiepileptic drug targets.
Beck H
Epilepsia; 2007; 48 Suppl 1():14-8. PubMed ID: 17316408
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of antiepileptic drug resistance.
Sisodiya SM
Curr Opin Neurol; 2003 Apr; 16(2):197-201. PubMed ID: 12644749
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of action of antiepileptic drugs and new antiepileptic drugs].
Armijo JA; Adin J; Sánchez MB
Rev Neurol; 2006 Oct; 43 Suppl 1():S17-41. PubMed ID: 17061186
[TBL] [Abstract][Full Text] [Related]
17. [Epigenetic modifications of chromatin in epilepsy: a potential mechanism of pharmacoresistance?].
Sokhranyaeva LS; Aniol VA; Gulyaeva NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9. Vyp. 2):17-21. PubMed ID: 29213033
[TBL] [Abstract][Full Text] [Related]
18. Genetics of antiepileptic drug resistance.
Sisodiya SM; Marini C
Curr Opin Neurol; 2009 Apr; 22(2):150-6. PubMed ID: 19532038
[TBL] [Abstract][Full Text] [Related]
19. Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients.
Tremolizzo L; Difrancesco JC; Rodriguez-Menendez V; Riva C; Conti E; Galimberti G; Ruffmann C; Ferrarese C
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):47-51. PubMed ID: 22584634
[TBL] [Abstract][Full Text] [Related]
20. [Drug-resistant epilepsy].
Nakken KO; Taubøll E
Tidsskr Nor Laegeforen; 2009 Oct; 129(19):1986-9. PubMed ID: 19823202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
